IGC PHARMA INC (IGC) Earnings History & Surprises
NYSEARCA:IGC • US45408X3089
0.2831 USD
-0.01 (-2.58%)
At close: Mar 12, 2026
0.2888 USD
+0.01 (+2.01%)
After Hours: 3/12/2026, 8:04:00 PM
Past quarterly earnings results for IGC PHARMA INC (IGC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateJun 25, 2026
PeriodQ3 / 2026
EPS Estimate-$0.02
Revenue Estimate328.25K
Last Reported
Release DateMar 2, 2026
PeriodQ2 / 2026
EPS Reported
EPS Surprise %
Revenue Surprise -41.81%
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | -0.02 | - | 18.80% | 191K | 328.25K | -41.81% | -53.64% | |
| Q1 2026 | -0.02 | -0.02 | 14.05% | 33.33% | 328K | 329.26K | -0.38% | 20.59% |
| Q4 2025 | -0.01 | -0.02 | 41.69% | 97.50% | 330K | 308.05K | 7.13% | 11.86% |
| Q3 2025 | -0.02 | -0.03 | 8.50% | - | 257K | 254.52K | 0.97% | 25.98% |
| Q2 2025 | -0.02 | -0.03 | 23.75% | - | 412K | 298.455K | 38.04% | 42.07% |
| Q1 2025 | -0.03 | -0.03 | -14.37% | - | 272K | 460.055K | -40.88% | -51.43% |
| Q4 2024 | -0.40 | -0.04 | -890.10% | - | 295K | 194.93K | 51.34% | 73.53% |
| Q3 2024 | - | - | 204K | - | -38.18% | |||
| Q2 2024 | - | - | 290K | - | 45.00% | |||
| Q1 2024 | - | - | 560K | - | 166.67% | |||
| Q4 2023 | - | - | 170K | - | 41.67% | |||
| Q3 2023 | - | - | 330K | - | 135.71% | |||
| Q2 2023 | - | - | 200K | - | 233.33% | |||
| Q1 2023 | -0.05 | - | - | 210K | - | 162.50% | ||
| Q4 2022 | - | - | 120K | - | 50.00% | |||
| Q3 2022 | -0.05 | - | - | 140K | - | 27.27% | ||
| Q2 2022 | - | - | 60K | - | -53.85% | |||
| Q1 2022 | - | - | 80K | - | -86.21% | |||
| Q4 2021 | - | - | 80K | - | 166.67% | |||
| Q3 2021 | - | - | 110K | - | -80.70% | |||
| Q2 2021 | - | - | 130K | - | -92.86% | |||
| Q1 2021 | - | - | 580K | - | -64.85% | |||
| Q4 2020 | - | - | 30K | - | - | |||
| Q3 2020 | - | - | 570K | - | - | |||
| Q2 2020 | - | - | 1.82M | - | - | |||
| Q1 2020 | - | - | 1.65M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-8.52%
Max Revenue beat (4)
7.13%
Min Revenue beat (4)
-41.81%
Analysis
IGC has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, IGC reported -8.5% below the revenue estimates on average.
IGC PHARMA INC / IGC Earnings FAQ
What is the most recent earnings date for IGC stock?
IGC PHARMA INC (IGC) last reported earnings on 3/2/2026.
Did IGC PHARMA INC (IGC) beat earnings estimates last quarter?
IGC PHARMA INC (IGC) missed EPS estimates and missed revenue estimates in the most recent quarter.